328 related articles for article (PubMed ID: 27381850)
61. The Impact of Dysregulated microRNA Biogenesis Machinery and microRNA Sorting on Neurodegenerative Diseases.
Weng YT; Chang YM; Chern Y
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834853
[TBL] [Abstract][Full Text] [Related]
62. microRNA diagnostic panel for Alzheimer's disease and epigenetic trade-off between neurodegeneration and cancer.
Nagaraj S; Zoltowska KM; Laskowska-Kaszub K; Wojda U
Ageing Res Rev; 2019 Jan; 49():125-143. PubMed ID: 30391753
[TBL] [Abstract][Full Text] [Related]
63. Understanding the Involvement of microRNAs in Mitochondrial Dysfunction and Their Role as Potential Biomarkers and Therapeutic Targets in Parkinson's Disease.
Tryphena KP; Anuradha U; Kumar R; Rajan S; Srivastava S; Singh SB; Khatri DK
J Alzheimers Dis; 2023; 94(s1):S187-S202. PubMed ID: 35848027
[TBL] [Abstract][Full Text] [Related]
64. Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients.
Zhang S; Ouyang X; Jiang X; Gu D; Lin Y; Kong SK; Xie W
Int J Med Sci; 2015; 12(7):590-8. PubMed ID: 26283876
[TBL] [Abstract][Full Text] [Related]
65. State of the Art of microRNAs Signatures as Biomarkers and Therapeutic Targets in Parkinson's and Alzheimer's Diseases: A Systematic Review and Meta-Analysis.
Zotarelli-Filho IJ; Mogharbel BF; Irioda AC; Stricker PEF; de Oliveira NB; Saçaki CS; Perussolo MC; da Rosa NN; Lührs L; Dziedzic DSM; Vaz RS; de Carvalho KAT
Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189731
[TBL] [Abstract][Full Text] [Related]
66. Circulating microRNAs in Neurodegenerative Diseases.
Grasso M; Piscopo P; Crestini A; Confaloni A; Denti MA
Exp Suppl; 2015; 106():151-169. PubMed ID: 26608203
[TBL] [Abstract][Full Text] [Related]
67. Potential utility of autoantibodies as blood-based biomarkers for early detection and diagnosis of Parkinson's disease.
DeMarshall CA; Han M; Nagele EP; Sarkar A; Acharya NK; Godsey G; Goldwaser EL; Kosciuk M; Thayasivam U; Belinka B; Nagele RG;
Immunol Lett; 2015 Nov; 168(1):80-8. PubMed ID: 26386375
[TBL] [Abstract][Full Text] [Related]
68. Downregulated serum miR-223 servers as biomarker in Alzheimer's disease.
Jia LH; Liu YN
Cell Biochem Funct; 2016 Jun; 34(4):233-7. PubMed ID: 27027823
[TBL] [Abstract][Full Text] [Related]
69. Biomarkers in Parkinson's disease (recent update).
Sharma S; Moon CS; Khogali A; Haidous A; Chabenne A; Ojo C; Jelebinkov M; Kurdi Y; Ebadi M
Neurochem Int; 2013 Sep; 63(3):201-29. PubMed ID: 23791710
[TBL] [Abstract][Full Text] [Related]
70. Plasma F2A isoprostane levels in Alzheimer's and Parkinson's disease.
Irizarry MC; Yao Y; Hyman BT; Growdon JH; Praticò D
Neurodegener Dis; 2007; 4(6):403-5. PubMed ID: 17934322
[TBL] [Abstract][Full Text] [Related]
71. MicroRNAs as Peripheral Biomarkers in Aging and Age-Related Diseases.
Kumar S; Vijayan M; Bhatti JS; Reddy PH
Prog Mol Biol Transl Sci; 2017; 146():47-94. PubMed ID: 28253991
[TBL] [Abstract][Full Text] [Related]
72. Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases.
Montine KS; Quinn JF; Zhang J; Fessel JP; Roberts LJ; Morrow JD; Montine TJ
Chem Phys Lipids; 2004 Mar; 128(1-2):117-24. PubMed ID: 15037157
[TBL] [Abstract][Full Text] [Related]
73. MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid.
Müller M; Kuiperij HB; Claassen JA; Küsters B; Verbeek MM
Neurobiol Aging; 2014 Jan; 35(1):152-8. PubMed ID: 23962497
[TBL] [Abstract][Full Text] [Related]
74. The potential of microRNAs as biofluid markers of neurodegenerative diseases--a systematic review.
Danborg PB; Simonsen AH; Waldemar G; Heegaard NH
Biomarkers; 2014 Jun; 19(4):259-68. PubMed ID: 24678935
[TBL] [Abstract][Full Text] [Related]
75. Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers.
Zen K; Zhang CY
Med Res Rev; 2012 Mar; 32(2):326-48. PubMed ID: 22383180
[TBL] [Abstract][Full Text] [Related]
76. Cell-free microRNAs in Parkinson's disease: potential biomarkers that provide new insights into disease pathogenesis.
Doxakis E
Ageing Res Rev; 2020 Mar; 58():101023. PubMed ID: 32001380
[TBL] [Abstract][Full Text] [Related]
77. Differential expression of microRNAs in Alzheimer's disease brain, blood, and cerebrospinal fluid.
Takousis P; Sadlon A; Schulz J; Wohlers I; Dobricic V; Middleton L; Lill CM; Perneczky R; Bertram L
Alzheimers Dement; 2019 Nov; 15(11):1468-1477. PubMed ID: 31495604
[TBL] [Abstract][Full Text] [Related]
78. Serum heme oxygenase-1 levels are increased in Parkinson's disease but not in Alzheimer's disease.
Mateo I; Infante J; Sánchez-Juan P; García-Gorostiaga I; Rodríguez-Rodríguez E; Vázquez-Higuera JL; Berciano J; Combarros O
Acta Neurol Scand; 2010 Feb; 121(2):136-8. PubMed ID: 19785642
[TBL] [Abstract][Full Text] [Related]
79. microRNAs involved in Parkinson's disease: A systematic review.
da Silva FC; Iop RD; Vietta GG; Kair DA; Gutierres Filho PJ; de Alvarenga JG; da Silva R
Mol Med Rep; 2016 Nov; 14(5):4015-4022. PubMed ID: 27666518
[TBL] [Abstract][Full Text] [Related]
80. Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases.
Weiland M; Gao XH; Zhou L; Mi QS
RNA Biol; 2012 Jun; 9(6):850-9. PubMed ID: 22699556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
